Hyperemesis Gravidarum News and Research

RSS

A post-‘Roe’ world in Georgia will mean more restrictions — and more political battles

Jerisha Morton didn't realize she was pregnant until about six weeks into her pregnancy. She soon started feeling waves of intense nausea.

24 Jun 2022

Improving our understanding of a severe pregnancy sickness (Hyperemesis Gravidarum)

News-Medical talks to Dr. Marlena Fejzo about a breakthrough in the understanding of hyperemesis gravidarum, and how it could improve maternal health around the world.

5 Apr 2022

Severe morning sickness raises depression risk

Severe morning sickness increases the risk of depression both during and after pregnancy, new research has found.

13 Oct 2020

Professional emotional support needed for women during high-risk pregnancies

Little is known about how women manage emotional distress during high-risk pregnancies, but Rutgers researchers learned that without psychosocial support, women struggle with fears and tears while feeling isolated and worried.

16 Dec 2019

Study shows association between severe morning sickness and autism spectrum disorder

Children whose mothers had hyperemesis gravidarum -- a severe form of a morning sickness -- during pregnancy were 53% more likely to be diagnosed with autism spectrum disorder, according to Kaiser Permanente research published in the American Journal of Perinatology.

3 Oct 2019

Severe vomiting in early pregnancy linked to increased autism risk

A new study published in the American Journal of Perinatology shows a 53% increased risk of autism spectrum disorder in children born to women who had excessively severe nausea and vomiting in pregnancy.

3 Oct 2019

Largest study of women with hyperemesis gravidarum launches in Europe

Women with severe sickness during pregnancy are being invited to join the largest study of the condition in Europe, led by Guy's and St Thomas' NHS Foundation Trust and King's College London.

16 May 2019

Management of nausea and vomiting in pregnancy costs the NHS more than previously thought

The economic cost to the NHS of vomiting and nausea during pregnancy is over £60 million, higher than previously thought, according to new estimates by the University of Warwick.

17 Dec 2018

New findings on extreme nausea and vomiting in pregnancy

Morning sickness- nausea and vomiting during pregnancy- occurs in up to 90 percent of women. Even animals, including a Gorilla named Calaya, have experienced it, too.

14 May 2018

Study reveals genes that cause extreme nausea and vomiting in pregnancy

Researchers have identified two genes that are associated with severe nausea and vomiting during pregnancy, a condition known of as hyperemesis gravidarum.

22 Mar 2018

Study identifies two genes associated with extreme nausea and vomiting during pregnancy

Most women experience some morning sickness during pregnancy, but about 2 percent of pregnant women experience a more severe form of nausea and vomiting.

21 Mar 2018

Ten steps for a healthy pregnancy

The Ten Steps for a Healthy Pregnancy, aims to offer mums-to-be essential advice to adopt good habits for healthy growth and development for both mum and baby.

14 Feb 2017

UCLA study shows anti-nausea drug does not increase risk of birth defects

Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart defects and cleft palate in children exposed in utero.

10 May 2016

Extreme morning sickness during pregnancy linked to developmental problems in children

Women who experience extreme morning sickness during pregnancy are three times more likely to have children with developmental issues, including attention disorders and language and speech delays, than woman who have normal nausea and vomiting, a UCLA study has found.

21 Apr 2015

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness.

10 Sep 2014

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013.

9 Jul 2013

Findings link antihistamine use to adverse pregnancy outcomes

Women with a severe form of morning sickness who take antihistamines to help them sleep through their debilitating nausea are significantly more likely to experience adverse pregnancy outcomes, including low birth weight babies and premature births, a UCLA study has found.

11 Jun 2013

Preemptive treatment effective for hyperemesis gravidarum and severe morning sickness

`In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, California, researchers will present data showing the effectiveness of preemptive treatment for hyperemesis gravidarum and severe morning sickness.

13 Feb 2013

Second trimester HG demands vigilance

Women who experience hyperemesis gravidarum during the second trimester have an increased risk for certain birth complications associated with placental abruption, study results show.

5 Feb 2013

Tzamal Medical, Duchesnay partner to distribute and sell Diclectin for management of NVP

Duchesnay Inc. and Tzamal Medical Group Ltd today announced that they have signed an agreement whereby Tzamal Medical Group has been granted exclusive rights to distribute and sell throughout the Israeli market the prescription medicine Diclectin (doxylamine 10 mg/pyridoxine 10 mg delayed-release tablet) indicated for the management of nausea and vomiting of pregnancy (NVP).

17 Jan 2013